Spots Global Cancer Trial Database for Tolerability Study of Trichostatin A In Subjects With Relapsed or Refractory Hematologic Malignancies
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Tolerability Study of Trichostatin A In Subjects With Relapsed or Refractory Hematologic Malignancies
Official Title: Tolerability Study of Trichostatin A In Subjects With Relapsed or Refractory Hematologic Malignancies
Study ID: NCT03838926
Interventions
Study Description
Brief Summary: The aim of this study is to investigate the safety and tolerability of trichostatin A in individuals with relapsed or refractory hematologic malignancies.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Vanda Investigational Site, Washington, District of Columbia, United States
Vanda Investigational Site, Lafayette, Indiana, United States
Vanda Investigational Site, Fairway, Kansas, United States
Vanda Investigational Site, Hackensack, New Jersey, United States
Vanda Investigational Site, Seattle, Washington, United States
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
